Yangliang Zhou

Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways

Qiang Xie, Yangliang Zhou, Guoqiang Lan et al. · Biochemical and Biophysical Research Communications · 2014 · 59 citations

Medicine, Oncology, Radiation Oncology +17

Strategy to enhance the anticancer efficacy of X-ray radiotherapy in melanoma cells by platinum complexes, the role of ROS-mediated signaling pathways

Qiang Xie, Guoqiang Lan, Yangliang Zhou et al. · Cancer Letters · 2014 · 42 citations

Medicine, Oncology, Radiation Oncology +16

Microwave‐Assisted Syntheses of Benzimidazole‐Containing Selenadiazole Derivatives That Induce Cell‐Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway

Yuanwei Liang, Yangliang Zhou, Shulin Deng et al. · ChemMedChem · 2016 · 38 citations

Medicine, Medicinal Chemistry, Oncology +13

Rational Design of Cancer-Targeted Benzoselenadiazole by RGD Peptide Functionalization for Cancer Theranostics

Li–Ye Yang, Wenying Li, Yanyu Huang et al. · Macromolecular Rapid Communications · 2015 · 18 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +17